Empatica received FDA 510(k) clearance for its Health Monitoring Platform for Parkinson's, its 12th FDA clearance. The system pairs Empatica's clinical-grade wearable with a patient app and clinician portal to continuously track Parkinson's symptoms, including tremor, slowness of movement, involuntary movements, sleep, and medication compliance. It builds on the company's 2025 acquisition of PKG Health, folding PKG's established Parkinson's measures into Empatica's wearable platform.